125 related articles for article (PubMed ID: 2886499)
1. A new endo-beta-galactosidase releasing Gal alpha 1----3Gal from carbohydrate moieties of glycoproteins and from a glycolipid.
Fushuku N; Muramatsu H; Uezono MM; Muramatsu T
J Biol Chem; 1987 Jul; 262(21):10086-92. PubMed ID: 2886499
[TBL] [Abstract][Full Text] [Related]
2. A novel endo-beta-galactosidase from Clostridium perfringens that liberates the disaccharide GlcNAcalpha 1-->Gal from glycans specifically expressed in the gastric gland mucous cell-type mucin.
Ashida H; Anderson K; Nakayama J; Maskos K; Chou CW; Cole RB; Li SC; Li YT
J Biol Chem; 2001 Jul; 276(30):28226-32. PubMed ID: 11382776
[TBL] [Abstract][Full Text] [Related]
3. Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences.
Clark GF; Krivan HC; Wilkins TD; Smith DF
Arch Biochem Biophys; 1987 Aug; 257(1):217-29. PubMed ID: 3115180
[TBL] [Abstract][Full Text] [Related]
4. A new endo-beta-galactosidase acting on the Gal beta 1-3Gal linkage of the proteoglycan linkage region.
Takagaki K; Nakamura T; Takeda Y; Daidouji K; Endo M
J Biol Chem; 1992 Sep; 267(26):18558-63. PubMed ID: 1526992
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of an endo-beta-galactosidase from Bacteroides fragilis.
Scudder P; Uemura K; Dolby J; Fukuda MN; Feizi T
Biochem J; 1983 Aug; 213(2):485-94. PubMed ID: 6412685
[TBL] [Abstract][Full Text] [Related]
6. Single mid-chain GlcNAc beta 1-6Gal beta 1-4R sequences of linear oligosaccharides are resistant to endo-beta-galactosidase of Bacteroides fragilis.
Renkonen O; Penttilä L; Niemelä R; Leppänen A
Glycoconj J; 1991 Aug; 8(4):376-80. PubMed ID: 1841679
[TBL] [Abstract][Full Text] [Related]
7. Endo-beta-D-galactosidases of Bacteroides fragilis and Escherichia freundii hydrolyze linear but not branched oligosaccharide domains of glycolipids of the neolacto series.
Scudder P; Hanfland P; Uemura K; Feizi T
J Biol Chem; 1984 May; 259(10):6586-92. PubMed ID: 6427218
[TBL] [Abstract][Full Text] [Related]
8. Keratanase digestion of keratan sulphates: characterization of large oligosaccharides from the N-acetyllactosamine repeat sequence and from the non-reducing terminal chain caps.
Huckerby TN; Dickenson JM; Brown GM; Nieduszynski IA
Biochim Biophys Acta; 1995 May; 1244(1):17-29. PubMed ID: 7766655
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel endo-beta-galactosidase specific for releasing the disaccharide GlcNAc alpha 1-->4Gal from glycoconjugates.
Ashida H; Maskos K; Li SC; Li YT
Biochemistry; 2002 Feb; 41(7):2388-95. PubMed ID: 11841232
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificity of endo-beta-galactosidases from Flavobacterium keratolyticus and Escherichia freundii is different from that of Pseudomonas sp.
Ito M; Hirabayashi Y; Yamagata T
J Biochem; 1986 Sep; 100(3):773-80. PubMed ID: 3096984
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a new endo-beta-galactosidase from Diplococcus pneumoniae.
Fukuda MN
Biochemistry; 1985 Apr; 24(9):2154-63. PubMed ID: 3922410
[TBL] [Abstract][Full Text] [Related]
12. Endo-beta-galactosidase releasing Ga1(alpha 1----3)Gal.
Muramatsu T
Methods Enzymol; 1989; 179():496-500. PubMed ID: 2560128
[No Abstract] [Full Text] [Related]
13. Enzyme-aided construction of medium-sized alditols of complete O-linked saccharides. The constructed hexasaccharide alditol Gal beta 1-4GlcNAc beta 1-6Gal beta 1-4GlcNAc beta 1-6(Gal beta 1-3)GalNAc-ol resists the action of endo-beta-galactosidase from Bacteroides fragilis.
Maaheimo H; Penttilä L; Renkonen O
FEBS Lett; 1994 Jul; 349(1):55-9. PubMed ID: 8045302
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of the blood group P antigen-like GalNAc beta 1-->3Gal beta 1-->4GlcNAc/Glc structure: a novel N-acetylgalactosaminyltransferase in human blood plasma.
Takeya A; Hosomi O; Shimoda N; Yazawa S
J Biochem; 1992 Sep; 112(3):389-95. PubMed ID: 1429528
[TBL] [Abstract][Full Text] [Related]
15. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.
Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA
Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of sulphated oligosaccharides released from bovine corneal keratan sulphate by the action of endo-beta-galactosidase.
Scudder P; Tang PW; Hounsell EF; Lawson AM; Mehmet H; Feizi T
Eur J Biochem; 1986 Jun; 157(2):365-73. PubMed ID: 2423331
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of terminal Gal alpha 1----3Gal beta 1----4GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal:N-acetyllactosaminide alpha 1----3-galactosyltransferase from calf thymus.
Blanken WM; Van den Eijnden DH
J Biol Chem; 1985 Oct; 260(24):12927-34. PubMed ID: 3932335
[TBL] [Abstract][Full Text] [Related]
18. The linear tetrasaccharide, Gal beta 1-4GlcNAc beta 1-6Gal beta 1-4GlcNAc, isolated from radiolabeled teratocarcinoma poly-N-acetyllactosaminoglycan resists the action of E. freundii endo-beta-galactosidase.
Renkonen O; Penttilä L; Makkonen A; Niemelä R; Leppänen A; Helin J; Vainio A
Glycoconj J; 1989; 6(1):129-40. PubMed ID: 2535473
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay.
Thall A; Galili U
Biochemistry; 1990 Apr; 29(16):3959-65. PubMed ID: 2354167
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies that recognize the trisaccharide epitope Gal alpha 1-3Gal beta 1-4GlcNAc present on Ehrlich tumor cell membrane glycoproteins.
Takagaki M; Knibbs RN; Roth J; Goldstein IJ
Histochemistry; 1993 Aug; 100(2):139-47. PubMed ID: 7503969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
